Clik here to view.
Consumer expenditure on FDA regulated products: 20 cents of every dollar
By: Sheri Walker, Ph.D., and Clark Nardinell One of the much-cited statistics about FDA is this: that FDA-regulated products account for about 20 cents of every dollar of annual spending by U.S....
View ArticleClik here to view.
Abbott looks to mollify EU regulators on St. Jude Medical merger; sues Alere...
Abbott (NYSE:ABT) made moves yesterday on a pair of pending, multi-billion-dollar acquisitions, its $25 billion merger with St. Jude Medical (NYSE:STJ) and a $6 billion union with Alere (NYSE:ALR). The...
View ArticleClik here to view.
Mylan, Teva crash as DOJ could file charges by end of year
The U.S. Justice Dept. could reportedly file charges in its generic-drug pricing probe into companies including Mylan Pharmaceuticals (NSDQ:MYL) and Teva Pharmaceuticals (NYSE:TEVA) by the end of...
View ArticleClik here to view.
Mast Therapeutics touts interim data from pulmonary hypertension study
Mast Therapeutics (NYSE:MSTX) touted interim data from a Phase II study of its AIR001 candidate in patients with pulmonary hypertension (PH) and PH associated with heart failure with preserved...
View ArticleClik here to view.
Swiss researchers develop material that goes highly flexible to rigid
Researchers from Switzerland’s École Polytechnique Fédérale de Lausanne (EPFL) have developed a composite material made from silicone and copper alloy that can morph from being highly flexible to rigid...
View ArticleClik here to view.
Navidea reels in losses, boosts sales in Q3
Shares in Navidea (NYSE:NAVB) rose yesterday after the company met expectations on Wall Street with its 3rd quarter results. The Dublin, Ohio-based company pared its losses by -99.3% to -$59,377 on...
View ArticleClik here to view.
Study shows knee injuries change the brain
A new study shows that when you injure your knee, it changes your brain – which could put you at risk for further injuries. Using MRI, researchers at The Ohio State University Wexner Medical Center...
View ArticleClik here to view.
Appeals court denies inventor in patent spat with Endologix pickup TriVascular
A federal appeals court yesterday upheld a lower court’s ruling on the claim construction in a patent infringement dispute between the inventor of a vascular stent patent and Endologix (NSDQ:ELGX)...
View ArticleClik here to view.
FDA releases September 2016 510(k) clearances
510(K) SUMMARIES OR 510(K) STATEMENTS FOR FINAL DECISIONS RENDERED DURING THE PERIOD September 2016 TOTAL 510(k)s THIS PERIOD 257 TOTAL WITH SUMMARIES 250 TOTAL WITH STATEMENTS 7 DEVICE: BBX1, BBX2,...
View ArticleClik here to view.
Baxter CEO Almeida on creating a bridge between invention and innovation
“The part that separates most companies regarding innovation, those that truly get it, is the bridge between the invention and the innovation,” Baxter chairman & CEO Joe Almeida said last week at...
View ArticleClik here to view.
Boston Scientific extends $210 million tender offer for EndoChoice
Boston Scientific (NYSE:BSX) said today that it’s extending its $210 million tender offer for EndoChoice (NYSE:GI) and its line of devices for treating gastrointestinal disease. The $8-per-share tender...
View ArticleClik here to view.
Antibacterial coated suture wins WHO recommendation
Ethicon said today that its triclosan-coated suture was included in the new “Global Guidelines for the Prevention of Surgical Site Infections (SSI)” by the World Health Organization. The guidelines are...
View ArticleClik here to view.
Pulmatrix reports Q3 loss, revenue down 91%
Shares in Pulmatrix (NSDQ:PULM) rose slightly after the biotechnology company released its 3rd quarter results. The Lexington, Mass.-based company reeled in its losses 35% to $3.2 million compared to a...
View ArticleClik here to view.
LVAD dev CorWave raises $17.1m in Series B
Circulatory support device developer CorWave said today it raised $17.1 million in a Series B round of financing to support its novel left ventricular assist device. The round was led by new investor...
View ArticleClik here to view.
Regeneron boosts profits, misses revenue in Q3
Shares in Regeneron (NSDQ:REGN) gained today after the biopharmaceutical company crushed earnings expectations on Wall Street with its 3rd quarter results. The Tarrytown, New York-based company posted...
View ArticleClik here to view.
Lab models drug-eluting polymer beads in blood flow
Researchers from the University of Huddersfield developed a method to predict how drug-eluting polymer beads can affect the body if they are modified. The UK team published their work in the European...
View ArticleClik here to view.
Medicare revokes Alere’s Arriva division enrollment
Alere‘s (NYSE:ALR) Arriva division had its enrollment with the Centers for Medicaid & Medicare Services revoked this month, the company said today in a regulatory filing. Arriva, which develops...
View ArticleClik here to view.
Mako Surgical co-founder’s startup Magic Leap raised $1.4B for ‘mixed...
Mako Surgical co-founder Rony Abovitz has raised $1.4 billion for his newest venture, Magic Leap, a company focused on developing novel augmented reality that could find its way to the operating room....
View ArticleClik here to view.
MassDevice.com +5 | The top 5 medtech stories for November 4, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s...
View ArticleClik here to view.
SanBio touts 1-year data on stem cell transplant for stroke
SanBio Inc. (TYO:4592) released 1-year interim data from the phase 1/2a, open-label, single-arm dose escalation study of its intracerebral stem cell implant designed for stroke patients. The Mountain...
View Article